Mylan Dymista Nasal Spray Recall: Potential Glass in Bottles
Mylan recalls Dymista nasal spray due to potential glass fragments in bottles. This could cause injury if the glass breaks during use. Affected units were manufactured in India with specific lot numbers and expiration dates.
Use caution until it’s fixed
Presence of foreign substance: Potential for glass in the neck area of the glass bottles.
Contact the company
What happened, in plain English
Mylan is recalling Dymista nasal spray because glass fragments might be present in the bottle necks. This could lead to injury if the glass breaks during use. The recall affects specific lot numbers and expiration dates from India. Read more at govinfonow.com/recall/39852-mylan-dymista-nasal-spray-recall-potential-glass-in-bottles.
Source Summary by GovInfoNow · govinfonow.com/recall/39852-mylan-dymista-nasal-spray-recall-potential-glass-in-bottles · Updated October 6, 2026 · FDA enforcement record: FDA #D-1075-2018
Cite this page
“Mylan Dymista Nasal Spray Recall: Potential Glass in Bottles.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39852-mylan-dymista-nasal-spray-recall-potential-glass-in-bottles. Based on FDA recall #D-1075-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1075-2018%22&limit=1).
Why it’s dangerous
Glass fragments in the bottle necks could break during use, potentially causing injury to the nasal passages or face. This is a risk if the glass breaks while the spray is being used.
Who’s affected
People with prescriptions for Dymista nasal spray who received this specific product from India. Those using the spray regularly are at higher risk if glass fragments are present.
How to tell if you have this one
Check for the product name Dymista, 137 mcg / 50 mcg per spray, and the lot numbers GA70246 or GA70254. The expiration date is February 2019.
- Brand
Mylan- Category
Drug
What to do — step by step
Check Product Details
Look for the lot numbers GA70246 or GA70254 and expiration date February 2019 on the product label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 13 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Mylan recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1075-2018 (July 25, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1075-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.